Acylated pyrimidine nucleosides for treatment of systemic inflam

Details Acylated pyrimidine nucleosides for treatment of systemic inflam Acylated pyrimidine nucleosides for treatment of systemic inflam

1995-06-05

1997-11-25

Kunz, Gary L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 49, A61K 3170, C07H 19067

Patent

active

056913206

ABSTRACT:
Pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine, and orotate, and uridine phosphorylase inhibitors, and their use in enhancing resistance to sepsis or systemic inflammation are disclosed.

REFERENCES:
patent: 3868451 (1975-02-01), Stein et al.
patent: 4613604 (1986-09-01), Chu et al.
patent: 4757139 (1988-07-01), Kawaguchi et al.
patent: 4874602 (1989-10-01), Calabresi et al.
Aderka et al., "Med Hypotheses", (1988), 27:193-6.
Arai M. et al, "Hepatology" (1989) 9:846-851.
Bowers et al., "J. Surg. Res." (1989) 47:183-8.
Cerra et al, in "Molecular and Cellular Mechanisms of Septic Shock" 265-277, Alan R. Liss (1989).
Clark et al., "Am. J. Pathol." (1987), 129:192-9.
Echtenacher et al, "J. Immunol." 145:3762-3766 (1990).
Engelhardt, R. et al, "Cancer. Res." (1991), 51:2524-30.
Farrar and Corwin, Ann. "N.Y. Acad. Sci." 133:668-684 (1966).
Galanos et al, "PNAS", 76:5939-5943, (1979).
Gut et al, "J. Infect. Disease." (1984) 149:621.
Halacheva et al., "Toxicon" (1988), 26:571-576.
Havell, "J. Immunol." 139:4225-4231 (1987).
Kang et al., "J. Histochem. Cytochem." (1988), 36:665-678.
Kilpatrick et al, "Metabolism" (1989) 38:73-7.
Kimura et al, "Cancer, Chemother, Pharmacol" (1987); 20:223-9.
Lomanto et al, "Anesth. Analg." (1972), 51:264-270.
Markley et al, "J. Trauma" 10:598-607, (1970).
McClain CJ and Cohen DA, "Hepatology" (1989) 9:349-351.
Nolan JP, "Gastroenterology" 69:1346-1356 (1975).
Nolan, JP, "Hepatology" (1989), 10:887-91.
Nolan JP and Leibowitz AI, "Gastroenterology" (1978), 75:445-9.
O'Sullivan, "Aust. N.Z. J. Med.", (1973) 3:417-422.
Pappo et al, "J. Surg. Res." (1991) 51:106-12.
Pates et al., "Farmakol Toksikol" (1968), 31:717-719.
Rosenthal et al, "Toxicology" 56:239-251 (1989).
Seljelid, "Scand. J. Immunol." (1989), 29:181-92.
Shafer et al "Gastroenterology" (1961), 40:782-784.
Shirai et al "Acta Pathol. Jpn." (1987) 37:1127-1134.
Taki et al "Eur. Surg. Res." (1985), 17:140-9.
Tiegs et al "J. Clin. Invest." (1992) 90:196-203.
Van Bladel et al "Cytokine" (1991) 3:149-54.
van Groeningen et al "Proceedings of the AACR" (1987), 28:195.
Van Groeningen et al "Cancer Tret Rep." (1986), 70:745-50.
Viens et al "J. Immunother" (1992), 11:218-24.
Von Euler et al "J. Biol. Chem." (1963), 238:2464-2469.
Wang et al "Arch. Surg." (1991), 126:219-224.
Lehninger, Albert L., "Biochemistry" Second Edition, Worth Publishers, Inc. New York, 1975, pp. 735-736.
Martin et al., J. Pharm. Sci., V. 76, No. 2 (Feb. 1987) pp. 180-183 "Synthesis And Antiviral Activity of Various Esters of
Casida et al, Biochemical Pharmacology, V. 15, (1966) pp. 627-644 "3',5'-Diesters of 5-Fluoro-2'-Deoxyuridine and Thymidine: Hydrolysis by Esterases in Human, Mouse, and Insect Tissue."
Ensminger et al, Biochemical Pharmacology, V. 28 (1979) pp. 1541-1545 "Thymidine 5'-O-Pivaloate: a Prodrug Derivative of Thymidine with Potential Applications in High-Dose Methotrexate Therapy."
Martin et al, Cancer Research, V. 42 (Oct. 1982) pp. 3964-3970 "High-Dose 5-Fluorouracil with Delayer Uridine `Rescue` in Mice."

Affiliated with

Also associated with

Rating

Acylated pyrimidine nucleosides for treatment of systemic inflam does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acylated pyrimidine nucleosides for treatment of systemic inflam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated pyrimidine nucleosides for treatment of systemic inflam will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2107202